… In this review, we discuss which patients have the highest predicted VTE recurrence risk,
including an update on emerging personalized strategies. Finally, we will take a deep-dive into …

… Introduction Recurrent venous thromboembolism (… risk of recurrence could have therapeutic
implications. A prospective study was designed to validate the Ottawa risk score of recurrent …

… Yet, should we define low risk as a predicted risk of recurrent VTE up to 4%, the VPM identified
47% (324 out of 694 patients) as low risk. These findings thus compare favorably with the …

… Studies focusing on predicting risk of recurrence or bleeding in a selected study population
… only, studies describing genetic risk factors only and predictor finding studies were excluded. …

… Calibration plots for the VTE-PREDICT model for recurrent venous thromboembolism in …
on the predicted risk of recurrent venous thromboembolism according to the VTE-PREDICT risk …

… [11], trained radial basis ANNs to predict the risk for portal vein thrombosis in acute … [12]
used a neural model to predict the incidence of portosplenomesenteric venous thrombosis in …

… 2 Observed and predicted risk of recurrent venous thromboembolism for men and women
… Solid lines: observerd cumulative recurrence risk; dashed lines, predicted recurrence risk. …

… Validation of the clinical prediction rule for recurrent venous thromboembolism in cancer
patients: the Ottawa score. Supportive care in cancer: official journal of the Multinational …

… Venous thromboembolism at uncommon sites is discussed in … For this review, the term
DVT will refer to deep-vein thrombosis … Efforts to predict and prevent venous thromboembolic …

… The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …